What is Fara?
Fara, the Friedreich's Ataxia Research Alliance, operates as a nonprofit entity committed to eradicating Friedreich's ataxia. The organization channels its efforts into funding vital research initiatives, supporting clinical trials, and cultivating a global community united against the disease. By providing grants and collaborating with the FA research ecosystem, Fara actively works to accelerate the development of new treatments and improve the quality of life for affected individuals. Their strategic focus is on driving research progress and offering comprehensive resources and advocacy programs.
How much funding has Fara raised?
Fara has raised a total of $227K across 2 funding rounds:
Debt
$150K
Debt
$77K
Debt (2020): $150K with participation from PPP
Debt (2021): $77K led by PPP
Key Investors in Fara
PPP
Public-Private Partnership
PPP
Public-Private Partnership
Undisclosed Investors
What's next for Fara?
With its large-scale late-stage funding context, Fara is poised for significant advancements in its mission to cure Friedreich's ataxia. The recent substantial expansion capital is expected to fuel intensified research efforts, broaden the scope of clinical trials, and enhance global collaboration within the scientific community. This strategic investment will likely accelerate the translation of research findings into tangible therapeutic solutions, bringing Fara closer to achieving its overarching goal of eradicating the disease and supporting those impacted by it.
See full Fara company page
